Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicentre, Open-label, Post-registration Observational Study of Elpida Used in the First Line Therapy for HIV-1 Infected Patients Against the Background of Standard Baseline ART (NNRTIs + 2 NRTIs)

Next Previous
Trial Profile

Multicentre, Open-label, Post-registration Observational Study of Elpida Used in the First Line Therapy for HIV-1 Infected Patients Against the Background of Standard Baseline ART (NNRTIs + 2 NRTIs)

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Jan 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Elsulfavirine (Primary) ; Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Acronyms PASS
  • Sponsors Viriom

Most Recent Events

  • 30 Oct 2021 Results of an analysis assessing the 96- week interim efficacy and safety of Elsulfavirine presented at the 18th European AIDS Conference
  • 08 Oct 2020 Results presented at the 15th International Congress on Drug Therapy and HIV Infection
  • 25 Oct 2018 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top